Pricing of orphan drugs

Lancet. 2009 Feb 7;373(9662):462. doi: 10.1016/S0140-6736(09)60169-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Economics, Pharmaceutical / statistics & numerical data
  • Glutamates / economics*
  • Glutamates / therapeutic use
  • Humans
  • Orphan Drug Production / economics*
  • Rare Diseases / drug therapy
  • Therapeutic Equivalency

Substances

  • Glutamates
  • N-carbamylglutamate